Related Experiment Video
Updated: Jul 24, 2026

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein
Y Hosohata1, E V Varga, D Stropova
1Department of Pharmacology, The University of Arizona, Tucson 85724, USA.
Abstract:
Intrinsic activities of different delta opioid agonists were determined in a [35S]GTPgammaS binding assay using cell membranes from Chinese hamster ovary (CHO) cells stably expressing the wild type (hDOR/CHO) or W284L mutant human delta opioid receptor (W284L/CHO). Agonist binding affinities were regulated more robustly by sodium and guanine nucleotide in W284L/CHO than in hDOR/ CHO cell membranes. The W284L mutation selectively reduced the affinity of SNC 80 while having moderate effect ((-) TAN 67) or no effect (DPDPE) on the affinities of other delta selective agonists. The mutation had opposite effects on the intrinsic activities of agonists belonging to different chemical classes. The effects of the mutation on agonist affinities and potencies were independent from its effects on the intrinsic activities of the agonists. Maximal stimulation of [35S]GTPgammaS binding by SNC 80 was 2-fold higher in W284L mutant cell membranes than in wild type hDOR/CHO cell membranes, despite lower receptor expression levels in the W284L/CHO cells. The binding affinity of SNC 80 however, was significantly reduced (15-fold and 30-fold in the absence or presence of sodium+GDP respectively) in W284L/CHO cell membranes relative to wild type hDOR/CHO membranes. Conversely, the Emax of (-)TAN 67 in the [35S]GTPgammaS binding assay was markedly reduced (0.6-fold of that of the wild type) with only a slight (6-fold) reduction in its binding affinity. The affinity and intrinsic activity of DPDPE on the other hand remained unchanged at the W284L mutant hDOR. The mutation had similar effects on the affinities potencies and intrinsic activities of (-)TAN 67 and SB 219825. The results indicate that delta opioid agonists of different chemical classes use specific conformations for G protein activation.
Insights
This study reveals how mutations in the human delta opioid receptor (hDOR) affect the binding and activity of different opioid agonists. Understanding these interactions is key to developing targeted pain relief medications.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- The delta opioid receptor (DOR) plays a crucial role in pain modulation and other physiological processes.
- Understanding the structure-activity relationships of DOR agonists is essential for developing selective therapeutics.
- Previous studies have explored various mutations affecting receptor function, but specific conformational changes remain to be elucidated.
Purpose of the Study:
- To investigate the impact of the W284L mutation in the human delta opioid receptor (hDOR) on the binding affinities and intrinsic activities of various delta opioid agonists.
- To determine if different chemical classes of delta opioid agonists utilize distinct receptor conformations for G protein activation.
Main Methods:
- Utilized a [35S]GTPgammaS binding assay to measure the intrinsic activities of delta opioid agonists.
- Employed Chinese hamster ovary (CHO) cells stably expressing either wild-type hDOR (hDOR/CHO) or the W284L mutant hDOR (W284L/CHO).
- Assessed agonist binding affinities in the presence and absence of sodium and guanine nucleotides.
Main Results:
- The W284L mutation differentially affected agonist binding affinities and intrinsic activities, with SNC 80 showing reduced affinity but higher maximal stimulation.
- Agonist binding affinities were more robustly regulated by sodium and guanine nucleotide in the W284L mutant compared to wild-type receptors.
- Different chemical classes of delta opioid agonists exhibited distinct responses to the W284L mutation, suggesting class-specific conformational states.
Conclusions:
- The W284L mutation in hDOR alters receptor function, impacting the affinity and efficacy of various delta opioid agonists.
- The findings support the hypothesis that delta opioid agonists of different chemical classes adopt specific conformations to activate G proteins.
- This research provides valuable insights into the conformational dynamics of the delta opioid receptor and its interactions with diverse agonists.
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Activation and Inactivation of G Proteins
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Opioid Receptors: Overview

